Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Alclometasone dipropionate + betamethasone valerate is a topical combination of two synthetic corticosteroids. Both components act as anti-inflammatory, antipruritic, and vasoconstrictive agents when applied to the skin. Alclometasone dipropionate is considered a low- to medium-potency corticosteroid used for relief of inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses such as eczema and atopic dermatitis[7][3]. Betamethasone valerate is a medium-potency corticosteroid indicated for similar conditions, including various forms of dermatitis and psoriasis[8][3]. The combination would be expected to provide enhanced anti-inflammatory effects compared to either agent alone by targeting multiple pathways involved in skin inflammation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on alclometasone dipropionate + betamethasone valerate.